Balyasny Asset Management »

Keros Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.1M 89k 45.70
2024-03-31 $1.7M 26k 66.20
2023-12-31 $704k 18k 39.76
2023-09-30 $1.4M 45k 31.88
2023-06-30 $415k 10k 40.18

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Keros Therapeutics

BlackRock
BlackRock
Vanguard Group
Darwin Global Management
T. Rowe Price Associates
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Leucadia National Corporation
TCG Crossover Management
Holocene Advisors
Woodline Partners
Geode Capital Management
Citadel Advisors
Braidwell

View all funds holding Keros Therapeutics